Lux Capital

Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.

Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.

CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.

CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.

Aira is dedicated to enhancing accessibility for individuals who are blind or have low vision. The company offers remote visual interpretation services through an app that connects users with highly trained Visual Interpreters. By streaming live video from the user's smartphone camera, these interpreters assist with a variety of tasks, including navigation and face recognition, enabling users to engage more fully in daily activities. Additionally, Aira has developed a wearable assistive product that utilizes smart glasses and an augmented reality dashboard, allowing certified agents to see what the user sees in real-time. This combination of technology and human support empowers visually impaired individuals to navigate their environments with greater independence and confidence.

Aira is dedicated to enhancing accessibility for individuals who are blind or have low vision. The company offers remote visual interpretation services through an app that connects users with highly trained Visual Interpreters. By streaming live video from the user's smartphone camera, these interpreters assist with a variety of tasks, including navigation and face recognition, enabling users to engage more fully in daily activities. Additionally, Aira has developed a wearable assistive product that utilizes smart glasses and an augmented reality dashboard, allowing certified agents to see what the user sees in real-time. This combination of technology and human support empowers visually impaired individuals to navigate their environments with greater independence and confidence.

Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.

Aira is dedicated to enhancing accessibility for individuals who are blind or have low vision. The company offers remote visual interpretation services through an app that connects users with highly trained Visual Interpreters. By streaming live video from the user's smartphone camera, these interpreters assist with a variety of tasks, including navigation and face recognition, enabling users to engage more fully in daily activities. Additionally, Aira has developed a wearable assistive product that utilizes smart glasses and an augmented reality dashboard, allowing certified agents to see what the user sees in real-time. This combination of technology and human support empowers visually impaired individuals to navigate their environments with greater independence and confidence.

Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.